1. Luo, Ming, Yang, Huiliang, Wu, Diwei, Huang, Shishu, Song, Yueming. 2022. Tent5a modulates muscle fiber formation in adolescent idiopathic scoliosis via maintenance of myogenin expression. In Cell proliferation, 55, e13183. doi:10.1111/cpr.13183. https://pubmed.ncbi.nlm.nih.gov/35137485/
2. Gewartowska, Olga, Aranaz-Novaliches, Goretti, Krawczyk, Paweł S, Prochazka, Jan, Dziembowski, Andrzej. . Cytoplasmic polyadenylation by TENT5A is required for proper bone formation. In Cell reports, 35, 109015. doi:10.1016/j.celrep.2021.109015. https://pubmed.ncbi.nlm.nih.gov/33882302/
3. Jovanovic, Milena, Marini, Joan C. 2024. Update on the Genetics of Osteogenesis Imperfecta. In Calcified tissue international, 115, 891-914. doi:10.1007/s00223-024-01266-5. https://pubmed.ncbi.nlm.nih.gov/39127989/
4. Hu, Jiali, Zeng, Lei, Hu, Ronghuan, Liu, Mengmeng, Ding, Jianwu. . TENT5A Increases Glioma Malignancy and Promotes its Progression. In Recent patents on anti-cancer drug discovery, 20, 45-54. doi:10.2174/0115748928280901231206102637. https://pubmed.ncbi.nlm.nih.gov/38204269/
5. Min, Xuejie, Lin, Fen, Zhao, Xinge, Li, Jinjun, Li, Hong. 2024. TENT5A mediates the cancer-inhibiting effects of EGR1 by suppressing the protein stability of RPL35 in hepatocellular carcinoma. In Cellular oncology (Dordrecht, Netherlands), 47, 2247-2264. doi:10.1007/s13402-024-01014-9. https://pubmed.ncbi.nlm.nih.gov/39570560/